resveratrol has been researched along with Cirrhoses, Experimental Liver in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, J; Ma, Z; Wu, S; Xu, M; Xue, W | 1 |
Hong, SS; Hong, SW; Jung, KH; Lee, DH; Lee, HS; Park, IS; Suh, JK; Zheng, HM | 1 |
Bosch, J; Di Pascoli, M; Diví, M; García-Pagán, JC; Gracia-Sancho, J; Rodríguez-Vilarrupla, A; Rosado, E; Vilaseca, M | 1 |
Chávez, E; Moreno, MG; Muriel, P; Reyes-Gordillo, K; Segovia, J; Shibayama, M; Tsutsumi, V; Vergara, P | 1 |
Benedetti, A; Bolognini, L; Casini, A; D'Ambrosio, L; Di Sario, A; Ferretti, G; Orlandi, F; Ridolfi, F; Salzano, R; Svegliati-Baroni, G | 1 |
5 other study(ies) available for resveratrol and Cirrhoses, Experimental Liver
Article | Year |
---|---|
Resveratrol Reduces the Incidence of Portal Vein System Thrombosis after Splenectomy in a Rat Fibrosis Model.
Topics: Animals; Anticoagulants; Apoptosis; Blood Platelets; Enoxaparin; Fibrinolytic Agents; Liver Cirrhosis, Experimental; Male; Nitric Oxide; Platelet Aggregation; Portal Vein; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Splenectomy; Stilbenes; Venous Thrombosis | 2016 |
The protective effect of resveratrol on dimethylnitrosamine-induced liver fibrosis in rats.
Topics: Animals; Antioxidants; Biomarkers; Body Weight; Dimethylnitrosamine; Lipid Peroxidation; Liver; Liver Cirrhosis, Experimental; Male; Organ Size; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2010 |
Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
Topics: Animals; Antioxidants; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypertension, Portal; Liver; Liver Cirrhosis; Liver Cirrhosis, Experimental; Male; Nitric Oxide Synthase Type III; Portal Pressure; Rats; Rats, Wistar; Resveratrol; Stilbenes; Thromboxane A2 | 2013 |
Resveratrol prevents fibrosis, NF-kappaB activation and TGF-beta increases induced by chronic CCl4 treatment in rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Bilirubin; Carbon Tetrachloride; Glutathione; Glutathione Disulfide; Glycogen; Lipid Peroxidation; Liver; Liver Cirrhosis, Experimental; Male; NF-kappa B; Protective Agents; Rats; Rats, Wistar; Resveratrol; Stilbenes; Transforming Growth Factor beta | 2008 |
The Na+/H+ exchanger modulates the fibrogenic effect of oxidative stress in rat hepatic stellate cells.
Topics: Animals; Antioxidants; Carcinogens; Cell Cycle; Cell Division; Cells, Cultured; Collagen; Culture Media; Ferric Compounds; Fluoresceins; Fluorescent Dyes; Kinetics; Liver; Liver Cirrhosis, Experimental; Malondialdehyde; Nitrilotriacetic Acid; Oxidative Stress; Rats; Resveratrol; Sodium-Hydrogen Exchangers; Stilbenes; Thiobarbituric Acid Reactive Substances | 1999 |